Aminopyridine Analogs Selectively Target Metastatic Pancreatic Cancer

6-aminopicolamine (6AP) acted as a water-soluble prodrug that was converted into intracellular bioactive metabolites that inhibited phosphogluconate dehydrogenase in vitro, and 6AP monotherapy demonstrated anti-metastatic efficacy with minimal toxicity in vivo.